Search

Your search keyword '"Lycklama A. Nijeholt, Geert"' showing total 390 results

Search Constraints

Start Over You searched for: Author "Lycklama A. Nijeholt, Geert" Remove constraint Author: "Lycklama A. Nijeholt, Geert"
390 results on '"Lycklama A. Nijeholt, Geert"'

Search Results

1. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands

3. Comparison of diffusion weighted imaging b0 with T2*-weighted gradient echo or susceptibility weighted imaging for intracranial hemorrhage detection after reperfusion therapy for ischemic stroke

4. Sex Differences in Prehospital Identification of Large Vessel Occlusion in Patients With Suspected Stroke

5. Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions: A MR CLEAN Registry Study

6. Prediction of Outcome and Endovascular Treatment Benefit

8. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice

9. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

11. Comparison of Prehospital Assessment by Paramedics and In-Hospital Assessment by Physicians in Suspected Stroke Patients: Results From 2 Prospective Cohort Studies

12. Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study

13. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

14. Interobserver Agreement on Intracranial Hemorrhage on Magnetic Resonance Imaging in Patients With Ischemic Stroke

16. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial

17. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands

18. Development and Validation of a Prediction Model for Failure of the Transfemoral Approach of Endovascular Treatment for Large Vessel Occlusion Acute Ischemic Stroke.

19. Intravenous Thrombolysis Before Endovascular Treatment in Posterior Circulation Occlusions:A MR CLEAN Registry Study

20. Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry

21. Economic Evaluation of Endovascular Treatment for Acute Ischemic Stroke

23. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

24. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

25. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

26. Path From Clinical Research to Implementation: Endovascular Treatment of Ischemic Stroke in the Netherlands

31. Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy

32. Validity of Early Outcomes as Indicators for Comparing Hospitals on Quality of Stroke Care

33. Endovascular treatment for isolated posterior cerebral artery occlusion stroke in the MR CLEAN registry

34. Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands:a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

35. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke:A Randomized Clinical Trial

36. Comparison of diffusion weighted imaging b0 with T2*-weighted gradient echo or susceptibility weighted imaging for intracranial hemorrhage detection after reperfusion therapy for ischemic stroke

37. Prognostic Value of Thrombus Volume and Interaction With First-Line Endovascular Treatment Device Choice

38. Thrombus Migration Paradox in Patients With Acute Ischemic Stroke

39. Workflow Intervals of Endovascular Acute Stroke Therapy During On- Versus Off-Hours: The MR CLEAN Registry

42. Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.

44. sj-docx-2-eso-10.1177_23969873231173274 – Supplemental material for Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy

45. sj-docx-1-eso-10.1177_23969873231173274 – Supplemental material for Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy

47. Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment

50. Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study

Catalog

Books, media, physical & digital resources